Humalog (insulin lispro) is a prescription drug that’s used to help treat diabetes. Humalog comes as a liquid solution for infusion or injection under the skin. Humalog comes in two versions: Humalog ...

NovoLog (insulin aspart) and Humalog (insulin lispro) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in certain ...

Humalog (insulin lispro) is a prescription drug that’s prescribed for diabetes in adults and certain children. The drug comes as a liquid solution for subcutaneous injection or intravenous (IV) ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

Improved Health Outcomes Noted with Dulaglutide Therapy Lilly announced the availability of lower-priced, non-branded versions of Humalog® Mix75/25™ KwikPen® (insulin lispro protamine and insulin ...

Humalog Junior KwikPen U-100 will be available as 5-count cartons. The BD pen needles are recommended for use with Humalog Junior KwiKPen. The Humalog Junior KwikPen (insulin lispro; Eli Lilly), a ...

INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...

Humalog Junior KwikPen [insulin lispro injection 100 units/mL] is now available by prescription for the treatment of diabetes in the US This innovation is the latest in the treatment and delivery ...

Humalog (insulin lispro) is a prescription medication used to manage blood sugar levels in people with type 1 and type 2 diabetes. Your doctor will determine the appropriate dosage of Humalog based on ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to ...

U.S. equity funds recorded a second weekly outflow in nine weeks in the week to May 20 as investors locked in profits from ‌a recent rally on caution over rising inflation and a surge in long-term ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...